- Issuer ticker
-
VTVT
- Reported as of
-
26 Jun 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
29 Jun 2026, 16:09:54 UTC
Filing notes and source
Key filing fact
Srinivas Akkaraju filed Form 4 for vTv Therapeutics Inc. (VTVT) on 29 Jun 2026.
Key facts
- This page summarizes Srinivas Akkaraju's Form 4 filing for vTv Therapeutics Inc. (VTVT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 29 Jun 2026, 16:09.
Change
- Previous filing in this sequence was filed on 08 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001253170
Primary reporting owner
AKKARAJU SRINIVAS
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VTVT
transaction
Derivative
Director stock option (right to buy)
Award
- Transaction value
- Shares
- +6,000
- Change %
- +55%
- Price
-
$35.08*
- Shares after
- 16,983
- Date
- 26 Jun 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 6,000
- Exercise price
- $35.08
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote